NCT02363283 2020-08-21Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal MelanomaNational Cancer Institute (NCI)Phase 2 Completed37 enrolled 12 charts
NCT00412828 2015-02-19A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV MelanomaCelldex TherapeuticsPhase 1/2 Completed117 enrolled